Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Details

Title
Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
Author
Ting, Yan 1 ; Cui Heyang 1 ; Zhou, Yong 1 ; Yang, Bin 2 ; Kong Pengzhou 3 ; Zhang, Yingchun 3 ; Liu, Yiqian 3 ; Wang, Bin 4 ; Cheng Yikun 5 ; Li, Jiayi 6 ; Guo Shixing 3 ; Xu Enwei 7 ; Liu, Huijuan 3 ; Cheng, Caixia 8 ; Zhang, Ling 3 ; Chen, Ling 9 ; Zhuang Xiaofei 10 ; Yu, Qian 3 ; Yang, Jian 3 ; Ma, Yanchun 3 ; Li, Hongyi 3 ; Wang, Fang 3 ; Liu, Jing 11 ; Liu, Xuefeng 12 ; Su, Dan 13 ; Wang, Yan 14 ; Sun, Ruifang 15 ; Guo Shiping 10 ; Li, Yaoping 16 ; Cheng, Xiaolong 3 ; Liu, Zhihua 17   VIAFID ORCID Logo  ; Zhan Qimin 14 ; Cui Yongping 1 

 Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, PR China (GRID:grid.440601.7) (ISNI:0000 0004 1798 0578); Shanxi Medical University, Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018) 
 Shanxi Medical University, Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018); Shanxi Cancer Hospital, Department of Tumor Surgery, Taiyuan, PR China (GRID:grid.440201.3) (ISNI:0000 0004 1758 2596) 
 Shanxi Medical University, Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018) 
 Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, PR China (GRID:grid.440601.7) (ISNI:0000 0004 1798 0578); Taiyuan University of Technology, College of Information and Computer, Taiyuan, PR China (GRID:grid.440656.5) (ISNI:0000 0000 9491 9632) 
 University of California Berkeley, College of Letter & Science, Berkeley, USA (GRID:grid.47840.3f) (ISNI:0000 0001 2181 7878) 
 Anglo-Chinese School (Independent), Singapore, Singapore (GRID:grid.47840.3f) 
 Shanxi Medical University, Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018); Shanxi Cancer Hospital, Department of Pathology, Taiyuan, PR China (GRID:grid.440201.3) (ISNI:0000 0004 1758 2596) 
 Shanxi Medical University, Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018); Shanxi Medical University, Department of Pathology, the First Hospital, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018) 
 Nankai University Gynecology Obstetrics Hospital, Department of Pathology, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, PR China (GRID:grid.216938.7) (ISNI:0000 0000 9878 7032) 
10  Shanxi Cancer Hospital, Department of Tumor Surgery, Taiyuan, PR China (GRID:grid.440201.3) (ISNI:0000 0004 1758 2596) 
11  Shanxi Medical University, Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018); Shanxi Medical University, Department of General Surgery, the First Hospital, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018) 
12  Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, PR China (GRID:grid.440601.7) (ISNI:0000 0004 1798 0578) 
13  Zhejiang Cancer Hospital, Department of Pathology, Hangzhou, PR China (GRID:grid.417397.f) (ISNI:0000 0004 1808 0985) 
14  Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, PR China (GRID:grid.440601.7) (ISNI:0000 0004 1798 0578); Peking University Cancer Hospital & Institute, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Beijing, PR China (GRID:grid.412474.0) (ISNI:0000 0001 0027 0586) 
15  Tumor Biobank, Shanxi Cancer Hospital, Taiyuan, PR China (GRID:grid.440201.3) (ISNI:0000 0004 1758 2596) 
16  Affiliated Provincial Hospital of Shanxi Medical University, Department of Colorectal & Anal Surgery, Taiyuan, PR China (GRID:grid.263452.4) (ISNI:0000 0004 1798 4018) 
17  Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Beijing, PR China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471558875
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.